Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | ACHE | P22303 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | TTR | P02766 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | FLT3 | P36888 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8576981 | 0.85 | CYP3A4 (0.55) | CYP3A4LMNAKDM4EACHEMAPT | |
| SCHEMBL9788674 | 0.85 | CYP3A4 (0.51) | CYP3A4LMNAKDM4EACHEMAPT | |
| SCHEMBL8765708 | 0.83 | KDM4E (0.62) | CYP3A4LMNAKDM4EACHEMAPT | |
| SCHEMBL21921357 | 0.83 | CYP3A4 (0.58) | CYP3A4LMNAKDM4EACHEMAPT | |
| SCHEMBL418274 | 0.83 | ACHE (0.56) | CYP3A4LMNAKDM4EACHEMAPT | |
| SCHEMBL5682633 | 0.83 | ACHE (0.61) | CYP3A4LMNAKDM4EACHEMAPT | |
| SCHEMBL5421764 | 0.83 | CYP3A4 (0.44) | CYP3A4KDM4EMAPTPOLBCA12 | |
| SCHEMBL24436689 | 0.82 | CYP3A4 (0.56) | CYP3A4LMNAKDM4EACHEMAPT | |
| SCHEMBL377507 | 0.82 | CYP3A4 (0.52) | CYP3A4LMNAKDM4EACHEMAPT | |
| SCHEMBL10591054 | 0.82 | CYP3A4 (0.56) | CYP3A4LMNAKDM4EACHEMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 665 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250160380-A1 | NUTRITIONAL COMPOSITION FOR GASTROINTESTINAL ENVIRONMENT TO PROVIDE IMPROVED MICROBIOME AND METABOLIC PROFILE | MEAD JOHNSON NUTRITION COMPANY (US) | 2025-05-22 | — | — | US | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| US-20230114089-A1 | METHOD FOR INDUCING DOPAMINERGIC NEURON PROGENITOR CELLS | KYOTO UNIVERSITY (JP) | 2023-04-13 | — | — | US | claimed |
| US-11415583-B2 | Method, kit, and apparatus for cancer detection using urinary tumor markers | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2022-08-16 | — | — | US | claimed |
| CN-114144454-A | Improved operating time to open-run time ratio by adding phenolic catalysts to polyaspartic flooring formulations | 科思创有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-108273129-B | Anti-collapsibility and high-strength composite calcium phosphate bone cement and preparation method and application thereof | 暨南大学 | 2020-12-11 | — | — | CN | claimed |
| CN-107377005-B | Preparation method of visible light composite photocatalyst and textile finishing method thereof | 盐城工学院 | 2020-09-04 | — | — | CN | claimed |
| CN-106537145-B | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2020-08-25 | — | — | CN | claimed |
| US-20200253889-A1 | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF GLUCOSE INTOLERANCE RELATED CONDITIONS AND OBESITY. | Sorbonne Université (FR) | 2020-08-13 | — | — | US | claimed |
| EP-3691624-A1 | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF GLUCOSE INTOLERANCE RELATED CONDITIONS AND OBESITY. | Sorbonne Université (FR) | 2020-08-12 | — | — | EP | claimed |
| US-7598054-B2 | Rapid peptidoglycan-based assay for detection of bacterial contamination of platelets | IMMUNETICS, INC. (US) | 2009-10-06 | — | — | US | claimed |
| WO-2007127459-A2 | RAPID PEPTIDOGLYCAN-BASED ASSAY FOR DETECTION OF BACTERIAL CONTAMINATION OF PLATELETS | IMMUNETICS, INC. (US) | 2007-11-08 | — | — | WO | claimed |
| CN-1879672-A | Medicine containing effective components of sarcandra glabra, preparation method and application thereof | LIAN XIAOYUAN (CN) | 2006-12-20 | — | — | CN | claimed |
| US-20060269982-A1 | Rapid peptidoglycan-based assay for detection of bacterial contamination of platelets | IMMUNETICS, INC. (US) | 2006-11-30 | — | — | US | claimed |
| US-20050154058-A1 | Method of preparing hydroxytyrosol esters, esters thus obtained and use of same | UNIVERSIDAD DE SEVILLA (ES) | 2005-07-14 | — | — | US | claimed |
| EP-1541544-A1 | METHOD OF PREPARING HYDROXYTYROSOL ESTERS, ESTERS THUS OBTAINED AND USE OF SAME | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2005-06-15 | — | — | EP | claimed |
| US-6398857-B1 | ACCUSTIC PIEZOELECTRIC; HOT MELT INK JET PRINTING; BENZOIC ACID VEHICLE; ALKYL OR PHENYL CARBOXYLIC ACID VISCOSITY MODIFIER; RETAINS DESIRED HARDNESS | XEROX CORPORATION | 2002-06-04 | — | — | US | claimed |
| US-6280923-B1 | LIGHT-INSENSITIVE SILVER SALT OF AN ORGANIC CARBOXYLIC ACID; PHOTOSENSITIVE SILVER HALIDE; BINDER; ORGANIC REDUCING AGENT FOR SAID SUBSTANTIALLY LIGHT-INSENSITIVE SILVER SALT | AGFA-GEVAERT (BE) | 2001-08-28 | — | — | US | claimed |
| US-5382529-A | Forming a color with a phenol or aniline compound, quantitative analysis | CTS BIOCIDES LTD. (GB) | 1995-01-17 | — | — | US | claimed |
| US-4279870-A | Liquid-liquid extraction process for the recovery of tungsten from low level sources | GTE LABORATORIES INCORPORATED (US) | 1981-07-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050154058-A1 | Method of preparing hydroxytyrosol esters, esters thus obtained and use of same | HAAO, ACSL3, HACL2 | CYP3A4 508/4885LMNA 2511/4885KDM4E 3539/4885 |
| US-20200253889-A1 | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF GLUCOSE INTOLERANCE RELATED CONDITIONS AND OBESITY. | GPR119, CPT1A, GYS2 | CYP3A4 861/4885LMNA 2712/4885KDM4E 3720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.